174 related articles for article (PubMed ID: 29670844)
1. The Eeffect of Metformin Combined with Calcium-Vitamin D
Shojaei Zarghani S; Abbaszadeh S; Alizadeh M; Rameshrad M; Garjani A; Soraya H
Adv Pharm Bull; 2018 Mar; 8(1):97-105. PubMed ID: 29670844
[No Abstract] [Full Text] [Related]
2. Calcium and vitamin D
Shojaei Zarghani S; Soraya H; Alizadeh M
Eur J Nutr; 2018 Mar; 57(2):731-740. PubMed ID: 27988847
[TBL] [Abstract][Full Text] [Related]
3. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
4. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
5. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways.
Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA
Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068
[TBL] [Abstract][Full Text] [Related]
6. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
7. Yam Gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK/ACC/CPT-1 pathway.
Dai Y; Qiu C; Zhang D; Li M; Liu W
Lipids Health Dis; 2024 Jan; 23(1):28. PubMed ID: 38273354
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D improves hepatic steatosis in NAFLD
Du T; Xiang L; Zhang J; Yang C; Zhao W; Li J; Zhou Y; Ma L
Front Endocrinol (Lausanne); 2023; 14():1138078. PubMed ID: 37033263
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic protective effects of Vitamin D against high fat diet-induced metabolic syndrome in rats: One for all.
Mostafa DK; Nasra RA; Zahran N; Ghoneim MT
Eur J Pharmacol; 2016 Dec; 792():38-47. PubMed ID: 27789220
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway.
Reda D; Elshopakey GE; Albukhari TA; Almehmadi SJ; Refaat B; Risha EF; Mahgoub HA; El-Boshy ME; Abdelhamid FM
Front Pharmacol; 2023; 14():1164512. PubMed ID: 37261280
[No Abstract] [Full Text] [Related]
12. Effect of vitamin D
Lim H; Lee H; Lim Y
Exp Biol Med (Maywood); 2021 May; 246(10):1139-1147. PubMed ID: 33541129
[TBL] [Abstract][Full Text] [Related]
13. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
El Amrousy D; Abdelhai D; Shawky D
Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
[TBL] [Abstract][Full Text] [Related]
15. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
16. [Effects of liraglutide combined with vitamin D on non-alcoholic fatty liver induced by high fat in mice and its mechanism].
Wang F; Zhang HF
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 May; 36(3):261-264. PubMed ID: 32981283
[No Abstract] [Full Text] [Related]
17. Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity.
Woo SL; Xu H; Li H; Zhao Y; Hu X; Zhao J; Guo X; Guo T; Botchlett R; Qi T; Pei Y; Zheng J; Xu Y; An X; Chen L; Chen L; Li Q; Xiao X; Huo Y; Wu C
PLoS One; 2014; 9(3):e91111. PubMed ID: 24638078
[TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats.
Xia HM; Wang J; Xie XJ; Xu LJ; Tang SQ
Int J Mol Med; 2019 Oct; 44(4):1523-1530. PubMed ID: 31364723
[TBL] [Abstract][Full Text] [Related]
19. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
[TBL] [Abstract][Full Text] [Related]
20. Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy.
Zhang D; Ma Y; Liu J; Deng Y; Zhou B; Wen Y; Li M; Wen D; Ying Y; Luo S; Shi C; Pu G; Miao Y; Zou C; Chen Y; Ma L
Front Pharmacol; 2021; 12():689111. PubMed ID: 34366846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
